Anjee Davis
As seen in:
MSN,
Nature,
Wiley Online Library,
The Hill,
NewsBeezer,
The Cancer Letter,
Clinical Leader
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anjee Davis
05.08.23 -- Ensuring Patients' Voices Are Heard In Colorectal Cancer Research
You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. Clinical Sites | Patient Centricity | Patient Recruitment (Monday) Clinical Trial Technology (Tuesday) Decentralized Trials | Trial Management (Wednesday) Outsourcing Models | Regulatory & Compliance (Thursday) (Friday) Learn more about our personalized newsletters here.
More focus and funding will be critical to curing colon cancer
By Anjee Davis, MPPA, President, Fight Colorectal Cancer Colorectal cancer is projected to become the leading cause of cancer deaths in the 20-49 age group by 2030, according to a 2021 JAMA report. The study estimates that 153,000 people in the United States will be diagnosed with colon cancer in 2023 alone. Alarmingly, around 13% of these cases will occur in people under the age of 50, representing a 9% increase in cases in this age group since 2020.
More Focus And Funding Becomes Crucial To Curing Colorectal Cancer
Guest Column | April 12, 2023 By Anjee Davis, MPPA, president, Fight Colorectal Cancer Colorectal cancer is projected to become the leading cause of cancer deaths for those ages 20-49 by 2030, according to a 2021 JAMA report. The study estimates that in 2023 alone, 153,000 people in the United States will be diagnosed with colorectal cancer. Shockingly, about 13% of those cases will be among people under the age of 50, representing a 9% increase in cases in this age group since 2020.
Herman Suit, whose research underpinned precision radiation and proton beam therapy, dies at 93
Herman Suit, the great father figure of the Department of Radiation Oncology at Massachusetts General Hospital, and one of the colossi of American oncology, has just died at the age of 93. He lost his beloved wife and partner Joan last year and since then has been in assisted living close to family in California.
NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9
NIH is now required by law to direct grantee institutions to report senior personnel who are disciplined for misconduct, sexual or otherwise. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic. If your institution has a site license , please log in from on site or via your VPN to access this content. Login Subscribe
NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9
NIH is now required by law to direct grantee institutions to report senior personnel who are disciplined for misconduct, sexual or otherwise. All organizations that “receive funds through a grant or cooperative agreement during fiscal year 2022 and in future years” are now required to notify NIH when principal investigators or key personnel are removed from their position or are disciplined due to concerns about harassment, bullying, retaliation, or hostile working conditions.
Burnout from the elusive quest for quality
We live in an era of quality monitoring—from the quality of products, like water or refrigerators, to the quality of customer service received from repair technicians, food delivery services, and even customer service representatives. This drive for quality measurement has naturally spread into the world of medicine. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic.
NCI study: Interferon may reduce severity of COVID-19 in people with genetic factors
Researchers from NCI and their collaborators have discovered that people of European and African ancestries who were hospitalized for COVID-19 are more likely to carry a particular combination of genetic variants in a gene known as OAS1 than patients with mild disease who were not hospitalized. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic.
NCCN publishes new recommendations for treating children with brain tumors
National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for pediatric central nervous system cancers. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic. If your institution has a site license , please log in from on site or via your VPN to access this content. Login Subscribe
Whole exome sequencing predicts response to cancer immunotherapy
Researchers have developed a two-step approach using whole exome sequencing to zero in on genes and pathways that predict whether cancer patients will respond to immunotherapy. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic. If your institution has a site license , please log in from on site or via your VPN to access this content. Login Subscribe
Poziotinib is active in EGFR exon 20 mutant lung cancer with efficacy highly dependent on insertion location
A phase II clinical trial of poziotinib for non-small cell lung cancer with epidermal growth factor receptor exon 20 mutations, led by researchers at The University of Texas MD Anderson Cancer Center, found the drug had significant antitumor activity and the efficacy was highly dependent on the location of the exon 20 loop insertion, which may impact future clinical trials for EGFR exon 20 targeted therapies. To access this subscriber-only content please log in or renew your subscription.
FDA approves crizotinib for ALK-positive inflammatory myofibroblastic tumor
FDA approved crizotinib (Xalkori) for adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase-positive myofibroblastic tumors. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login ? Our IP Login system is now automatic. If your institution has a site license , please log in from on site or via your VPN to access this content. Login Subscribe
Abortion care, cancer, and the fate of American physicians
A journey through cancer treatment can be grueling, unforgiving, and treacherous for both patient and physician. But what happens when a pregnancy complicates the treatment? With the Supreme Court’s recent overturning of Roe v. Wade and Planned Parenthood v.
Patient engagement and advocacy considerations in development and implementation of a multicancer early detection program
Patient Advocacy in Cancer Prevention and Control One in 2 males and 1 in 3 females in the United States are expected to develop invasive cancer during their lifetime, and 1 in 5 will die from cancer.4-6 Population adoption of evidence-based cancer screening and timely, effective treatment can reduce mortality.4, 7-13 Both domestically and globally, organizations that advocate for patients with cancer aim to raise public awareness of cancer; promote acceptance and adoption of prevention and...
Medicare loophole for screening colonoscopies is fixed - What does this mean for patients?
© Getty Images Medicare loophole for screening colonoscopies is fixed — What does this mean for patients? There's no debate, 2020 was a difficult year. And we will certainly face our fair share of challenges in 2021. The global pandemic has shone a spotlight on health disparities that demand our attention to find and implement long-overdue solutions. While this country has a long way to go when it comes to health equity and ensuring access to care, we are making steps in the right direction.
Colorectal Cancer in the Young: Epidemiology, Prevention, Management
ADDITIONAL CARE CONSIDERATIONS IN PATIENTS WITH EO-CRC Sexuality With a rise in EO-CRC, there is a clear need to identify and address survivorship concerns that are unique to younger adults who may be married, unmarried, dating, or still exploring their sexuality. Sexual health is often neglected yet critically important for patients with EO-CRC, who may be reluctant to talk to their health care teams or unaware that interventions for sexual challenges may be available.
Giving every patient an opportunity to participate in and benefit from cancer progress
Last week, the American Cancer Society released its annual Facts and Figures report, showing that we continue to make exceptional progress against cancer, most notably with a 27 percent decline in the death rate across all cancer types over the last 25 years.
Stolen-colon storm could boost cancer screening
CORRESPONDENCE 09 January 2019 There were unforeseen benefits when a giant inflatable replica of a human colon was stolen last October from the University of Kansas Cancer Center in Kansas City. The model was intended as an interactive educational tool to increase the public’s cancer awareness, so the purpose of the prank is unclear. However, the story swept the globe on social media: the #stolencolon hashtag was shared more than 6,500 times, resulting in some 36 million impressions.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anjee
Contact Anjee, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack